Neutrophil	B:C1870887
gelatinase	I:C1870887
-	I:C1870887
associated	I:C1870887
lipocalin	I:C1870887
in	O
a	O
triphasic	O
rat	O
model	I:C0599779
of	O
adenine	O
-	O
induced	O
kidney	O
injury	I:C0160420
.	O

Neutrophil	O
gelatinase	I:C1870887
-	I:C1870887
associated	I:C1870887
lipocalin	I:C1870887
in	O
a	O
triphasic	O
rat	B:C0599779
model	I:C0599779
of	O
adenine	O
-	O
induced	O
kidney	O
injury	I:C0160420
.	O

Neutrophil	O
gelatinase	I:C1870887
-	I:C1870887
associated	I:C1870887
lipocalin	I:C1870887
in	O
a	O
triphasic	O
rat	O
model	I:C0599779
of	O
adenine	B:C0001407
-	O
induced	O
kidney	O
injury	I:C0160420
.	O

Neutrophil	O
gelatinase	I:C1870887
-	I:C1870887
associated	I:C1870887
lipocalin	I:C1870887
in	O
a	O
triphasic	O
rat	O
model	I:C0599779
of	O
adenine	O
-	O
induced	O
kidney	B:C0160420
injury	I:C0160420
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
NGAL	B:C1870887
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	O
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	O
tubulointerstitial	I:C0041349
insult	I:C0041349
caused	O
by	O
adenine	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
NGAL	O
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	B:C0005516
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	O
tubulointerstitial	I:C0041349
insult	I:C0041349
caused	O
by	O
adenine	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
NGAL	O
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	O
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	B:C0041349
tubulointerstitial	I:C0041349
insult	I:C0041349
caused	O
by	O
adenine	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
whether	O
NGAL	O
,	O
given	O
its	O
advantages	O
over	O
traditional	O
biomarkers	O
,	O
can	O
be	O
used	O
to	O
describe	O
the	O
dynamic	O
characteristics	O
of	O
the	O
renal	O
tubulointerstitial	I:C0041349
insult	I:C0041349
caused	O
by	O
adenine	B:C0001407
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	B:C1870887
as	O
a	O
biomarker	O
of	O
any	O
acute	O
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	O
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	O
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	O
model	I:C0599779
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	O
as	O
a	O
biomarker	B:C0005516
of	O
any	O
acute	O
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	O
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	O
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	O
model	I:C0599779
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	O
as	O
a	O
biomarker	O
of	O
any	O
acute	B:C2609414
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	O
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	O
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	O
model	I:C0599779
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	O
as	O
a	O
biomarker	O
of	O
any	O
acute	O
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	B:C0238304
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	O
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	O
model	I:C0599779
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	O
as	O
a	O
biomarker	O
of	O
any	O
acute	O
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	O
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	B:C1870887
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	O
model	I:C0599779
.	O

Subsequently	O
,	O
it	O
will	O
be	O
possible	O
to	O
assess	O
NGAL	O
as	O
a	O
biomarker	O
of	O
any	O
acute	O
kidney	I:C2609414
injury	I:C2609414
,	O
on	O
top	O
of	O
chronic	O
interstitial	I:C0238304
disease	I:C0238304
,	O
if	O
NGAL	O
levels	O
are	O
stable	O
through	O
the	O
chronic	O
phase	O
of	O
our	O
adenine	B:C0599779
model	I:C0599779
.	O

Study	B:C2348561
group	I:C2348561
rats	O
were	O
fed	O
an	O
adenine	O
diet	O
,	O
and	O
control	O
group	O
rats	O
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O

Study	O
group	I:C2348561
rats	B:C0034693
were	O
fed	O
an	O
adenine	O
diet	O
,	O
and	O
control	O
group	O
rats	O
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O

Study	O
group	I:C2348561
rats	O
were	O
fed	O
an	O
adenine	B:C0001407
diet	O
,	O
and	O
control	O
group	O
rats	O
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O

Study	O
group	I:C2348561
rats	O
were	O
fed	O
an	O
adenine	O
diet	B:C0012155
,	O
and	O
control	O
group	O
rats	O
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O

Study	O
group	I:C2348561
rats	O
were	O
fed	O
an	O
adenine	O
diet	O
,	O
and	O
control	O
group	O
rats	B:C0034693
were	O
fed	O
a	O
regular	O
diet	O
only	O
.	O

Blood	B:C0178913
and	O
urine	O
samples	I:C1610733
for	O
urea	O
,	O
creatinine	O
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	B:C1610733
samples	I:C1610733
for	O
urea	O
,	O
creatinine	O
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	O
samples	I:C1610733
for	O
urea	B:C0041942
,	O
creatinine	O
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	O
samples	I:C1610733
for	O
urea	O
,	O
creatinine	B:C0010294
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	O
samples	I:C1610733
for	O
urea	O
,	O
creatinine	O
and	O
NGAL	B:C1870887
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	O
samples	I:C1610733
for	O
urea	O
,	O
creatinine	O
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	B:C0034693
at	O
the	O
beginning	O
of	O
the	O
study	O
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Blood	O
and	O
urine	O
samples	I:C1610733
for	O
urea	O
,	O
creatinine	O
and	O
NGAL	O
were	O
drawn	O
from	O
each	O
rat	O
at	O
the	O
beginning	O
of	O
the	O
study	B:C0008972
and	O
after	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
and	O
8	O
weeks	O
.	O

Kidney	B:C0022646
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	B:C0034693
were	O
stained	O
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	B:C0487602
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
Hematoxylin	B:C0523207
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	B:C0523207
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	B:C0005186
actin	I:C0005186
stainings	O
.	O

Kidney	O
slices	O
from	O
these	O
rats	O
were	O
stained	O
with	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
(	O
Hematoxylin	O
-	I:C0523207
eosin	I:C0523207
)	O
and	O
β-	O
actin	I:C0005186
stainings	B:C0487602
.	O

Serum	B:C2945624
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
in	O
the	O
study	O
group	O
were	O
higher	O
than	O
baseline	O
and	O
than	O
in	O
the	O
control	O
group	O
;	O
these	O
differences	O
were	O
statistically	O
significant	O
in	O
some	O
of	O
the	O
intervals	O
.	O

Serum	O
urea	I:C2945624
,	O
creatinine	B:C0201975
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
in	O
the	O
study	O
group	O
were	O
higher	O
than	O
baseline	O
and	O
than	O
in	O
the	O
control	O
group	O
;	O
these	O
differences	O
were	O
statistically	O
significant	O
in	O
some	O
of	O
the	O
intervals	O
.	O

Serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	B:C1870887
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
in	O
the	O
study	O
group	O
were	O
higher	O
than	O
baseline	O
and	O
than	O
in	O
the	O
control	O
group	O
;	O
these	O
differences	O
were	O
statistically	O
significant	O
in	O
some	O
of	O
the	O
intervals	O
.	O

Tubulointerstitial	B:C0041349
changes	O
and	O
adenine	O
crystals	O
were	O
evident	O
in	O
the	O
study	O
group	O
rats	O
.	O

Tubulointerstitial	O
changes	O
and	O
adenine	B:C0001407
crystals	O
were	O
evident	O
in	O
the	O
study	O
group	O
rats	O
.	O

Tubulointerstitial	O
changes	O
and	O
adenine	O
crystals	O
were	O
evident	O
in	O
the	O
study	O
group	O
rats	B:C0034693
.	O

In	O
the	O
rats	B:C0034693
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	B:C0001407
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	B:C2945624
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	B:C1318439
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	B:C1870887
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	B:C1336825
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	B:C0160420
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	B:C0001407
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	B:C0012155
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	B:C2004454
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	O
function	I:C0232804
.	O

In	O
the	O
rats	O
fed	O
adenine	O
,	O
serum	O
urea	I:C2945624
,	O
creatinine	O
and	O
NGAL	O
levels	O
and	O
urinary	O
NGAL	O
/	O
creatinine	O
ratio	O
followed	O
a	O
triphasic	O
pattern	I:C1336825
of	O
kidney	O
injury	I:C0160420
:	O
an	O
acute	O
phase	O
while	O
on	O
the	O
adenine	O
diet	O
,	O
a	O
partial	O
recovery	O
phase	O
after	O
switching	O
to	O
the	O
regular	O
diet	O
and	O
a	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
phase	O
after	O
stabilization	O
of	O
renal	B:C0232804
function	I:C0232804
.	O

NGAL	B:C1870887
can	O
serve	O
a	O
biomarker	O
for	O
acute	O
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	O
rat	O
model	I:C0599779
.	O

NGAL	O
can	O
serve	O
a	O
biomarker	B:C0005516
for	O
acute	O
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	O
rat	O
model	I:C0599779
.	O

NGAL	O
can	O
serve	O
a	O
biomarker	O
for	O
acute	B:C2609414
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	O
rat	O
model	I:C0599779
.	O

NGAL	O
can	O
serve	O
a	O
biomarker	O
for	O
acute	O
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	O
rat	O
model	I:C0599779
.	O

NGAL	O
can	O
serve	O
a	O
biomarker	O
for	O
acute	O
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	B:C0041349
rat	O
model	I:C0599779
.	O

NGAL	O
can	O
serve	O
a	O
biomarker	O
for	O
acute	O
kidney	I:C2609414
injury	I:C2609414
and	O
possibly	O
for	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
in	O
the	O
tubulointerstitial	O
rat	B:C0599779
model	I:C0599779
.	O

